In the AD validation cohort (GSE32924), CD274 ranked highest (AUC ∼0.90), followed by SERPINB4, FOLH1, and SPRR1B, confirming consistent diagnostic utility across datasets (Figure 5D). Here, SERPINB4 is linked to Alzheimer disease.